| Primary |
| Drug Use For Unknown Indication |
52.6% |
| Angina Pectoris |
10.5% |
| Hypertension |
10.5% |
| Coronary Artery Disease |
5.3% |
| Antiplatelet Therapy |
3.5% |
| Prophylaxis |
3.5% |
| Agranulocytosis |
1.8% |
| Anticoagulant Therapy |
1.8% |
| Blood Pressure |
1.8% |
| Cardiac Disorder |
1.8% |
| Chest Pain |
1.8% |
| Coagulopathy |
1.8% |
| Hyperlipidaemia |
1.8% |
| Product Used For Unknown Indication |
1.8% |
|
| Death |
23.8% |
| Hyperglycaemia |
7.1% |
| Myocardial Infarction |
7.1% |
| Vith Nerve Paralysis |
7.1% |
| Cardio-respiratory Arrest |
4.8% |
| Cerebral Haemorrhage |
4.8% |
| Cerebrovascular Accident |
4.8% |
| Headache |
4.8% |
| Pneumonia Primary Atypical |
4.8% |
| Tinnitus |
4.8% |
| Vision Blurred |
4.8% |
| Bundle Branch Block Left |
2.4% |
| Diabetes Mellitus |
2.4% |
| Eczema |
2.4% |
| Haemorrhagic Cerebral Infarction |
2.4% |
| Hypotension |
2.4% |
| Jaundice |
2.4% |
| Medication Residue |
2.4% |
| Miosis |
2.4% |
| Muscle Spasms |
2.4% |
|
| Secondary |
| Product Used For Unknown Indication |
23.7% |
| Drug Use For Unknown Indication |
20.4% |
| Hypertension |
9.0% |
| Coronary Artery Disease |
5.7% |
| Prostate Cancer |
5.0% |
| Chest Pain |
3.7% |
| Diabetes Mellitus |
3.7% |
| Pulmonary Hypertension |
3.5% |
| Right Ventricular Failure |
3.3% |
| Angina Pectoris |
2.9% |
| Cardiac Failure Congestive |
2.9% |
| Cardiac Disorder |
2.6% |
| Parkinson's Disease |
2.2% |
| Arthralgia |
2.0% |
| Atrial Fibrillation |
1.8% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Cardiac Failure |
1.5% |
| Cardiac Failure Acute |
1.5% |
| Myocardial Infarction |
1.5% |
| Convulsion |
1.3% |
|
| Muscular Weakness |
11.1% |
| Hypotension |
9.9% |
| Weight Increased |
7.4% |
| Syncope |
6.2% |
| Urinary Tract Infection |
6.2% |
| Vomiting |
6.2% |
| Diabetes Mellitus |
4.9% |
| Off Label Use |
4.9% |
| Orthostatic Hypotension |
4.9% |
| Ventricular Dysfunction |
4.9% |
| Very Low Density Lipoprotein Increased |
4.9% |
| Death |
3.7% |
| Headache |
3.7% |
| Sickle Cell Anaemia With Crisis |
3.7% |
| Stent Placement |
3.7% |
| Troponin Increased |
3.7% |
| Dizziness |
2.5% |
| Drug Hypersensitivity |
2.5% |
| Palpitations |
2.5% |
| Presyncope |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.2% |
| Drug Use For Unknown Indication |
26.2% |
| Hypertension |
8.0% |
| Cardiac Disorder |
3.6% |
| Diabetes Mellitus |
3.3% |
| Pain |
2.9% |
| Angina Pectoris |
2.3% |
| Atrial Fibrillation |
2.1% |
| Prophylaxis |
1.9% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Blood Cholesterol Increased |
1.9% |
| Coronary Artery Disease |
1.7% |
| Type 2 Diabetes Mellitus |
1.6% |
| Depression |
1.6% |
| Coronary Artery Bypass |
1.5% |
| Asthma |
1.3% |
| Rheumatoid Arthritis |
1.3% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Cardiac Failure Congestive |
1.3% |
| Nuclear Magnetic Resonance Imaging |
1.2% |
|
| Vomiting |
12.9% |
| Myocardial Infarction |
10.3% |
| Weight Decreased |
9.5% |
| Weight Increased |
7.0% |
| Death |
5.1% |
| Nausea |
4.9% |
| Renal Failure |
4.8% |
| Pain |
4.7% |
| Pneumonia |
4.6% |
| Syncope |
4.2% |
| Renal Failure Acute |
4.1% |
| Thrombocytopenia |
4.0% |
| Chest Pain |
3.6% |
| Tremor |
3.2% |
| Unevaluable Event |
3.1% |
| Pruritus |
3.0% |
| Vision Blurred |
2.9% |
| Unresponsive To Stimuli |
2.8% |
| Drug Ineffective |
2.7% |
| Urinary Tract Infection |
2.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
28.6% |
| Myocardial Infarction |
28.6% |
| Product Used For Unknown Indication |
28.6% |
| Angina Pectoris |
14.3% |
|
| Loss Of Consciousness |
50.0% |
| Nausea |
50.0% |
|
